Cannabis Clinical Trials

The stock of Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) registered a decrease of 0.22% in short interest. ETTX’s total short interest was 45,800 shares in March as published by FINRA. Its down 0.22% from 45,900 shares, reported previously. With 21,300 shares average volume, it will take short sellers 2 days to cover their ETTX’s short positions. […]

by

The stock of Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) registered a decrease of 0.22% in short interest. ETTX’s total short interest was 45,800 shares in March as published by FINRA. Its down 0.22% from 45,900 shares, reported previously. With 21,300 shares average volume, it will take short sellers 2 days to cover their ETTX’s short positions. […]

by

Norman “Ned” Sharpless, M.D., director of the National Cancer Institute (NCI), will serve as acting Food and Drug Administration (FDA) commissioner starting in April, 2019, according to an announcement from Alex M. Azar III, the secretary of health and human services. The announcement was made a week after Scott Gottlieb, M.D., stated his resignation as […]

by

Norman “Ned” Sharpless, M.D., director of the National Cancer Institute (NCI), will serve as acting Food and Drug Administration (FDA) commissioner starting in April, 2019, according to an announcement from Alex M. Azar III, the secretary of health and human services. The announcement was made a week after Scott Gottlieb, M.D., stated his resignation as […]

by

That study, titled “Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs,” was led by Dr. Joseph Wakshlag of Cornell University. Wakshlag and colleagues measured the effects of a particular hemp-based cannabidiol product—ElleVet Sciences’ proprietary hemp oil blend—on pain and arthritis in a small sample of dogs. The results were remarkable: More than […]

by

What Characterizes Alzheimer’s? Alzheimer’s usually begins by attacking the brain’s hippocampus, a critical brain region in memory processing. This causes memory and cognitive impairments that define the initial stages of the disease. It also contributes to the anxiety, depression, and agitation from which AD patients also suffer. As the disease progresses through the rest of […]

by

Gainers Akari Therapeutics PLC (NASDAQ: AKTX) shares jumped 224.18 percent to close at $5.90 on Wednesday after the company had a successful Type B, pre-IND meeting with the FDA regarding Akari’s proposed pivotal clinical trial program for hematopoietic stem cell transplant-related thrombotic microangiopathy. Clean Energy Fuels Corp. (NASDAQ: CLNE) gained 28.63 percent to close at […]

by

Medlab Clinical Ltd’s (ASX:MDC) CEO Dr Sean Hall last night, presented a clinical NanaBis™ update to medical practitioners as part of on-going medical education. He explained several key aspects of NanaBis™, which is a highly purified proprietary blend of cannabis molecules cannabidiol (CBD) and tetrahydrocannabinol (THC). A summary was provided of five case studies from […]

by

LOD, Israel, March 4, 2019 /CNW/ — Panaxia in collaboration with the Israeli Pharmaceutical company “Rafa”, has begun a clinical research of medical cannabis concentrates for inhalation. This new method of delivery will increase accessibility mainly in cancer patients treated with long-term pharmaceutical cannabis (such as sublingual tablets), and suffering from acute cancer pain who […]

by